Ryosaku Azemoto

Sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Japan

Sadahisa Ogasawara, Yoshihiko Ooka, Norio Itokawa et al. · Investigational New Drugs · 2019 · 79 citations · Full text

Potential of Lenvatinib for an Expanded Indication from the REFLECT Trial in Patients with Advanced Hepatocellular Carcinoma

Susumu Maruta, Sadahisa Ogasawara, Yoshihiko Ooka et al. · Liver Cancer · 2020 · 78 citations · Full text

Safety and tolerance of sorafenib in Japanese patients with advanced hepatocellular carcinoma

Sadahisa Ogasawara, Fumihiko Kanai, Shuntaro Obi et al. · Hepatology International · 2011 · 46 citations

Hepatology, Hepatocellular Carcinoma, Medicine +9

Randomized controlled study of gemcitabine plus S-1 combination chemotherapy versus gemcitabine for unresectable pancreatic cancer

Kentaro Sudo, Takeshi Ishihara, Nobuto Hirata et al. · Cancer Chemotherapy and Pharmacology · 2013 · 43 citations

Urology, Oncology, Surgical Oncology +8

Posttreatment after Lenvatinib in Patients with Advanced Hepatocellular Carcinoma

Keisuke Koroki, Naoya Kanogawa, Susumu Maruta et al. · Liver Cancer · 2021 · 38 citations · Full text